Myriad Genetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.

About MYGN

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. 

CEO
Samraat S Raha
CEOSamraat S Raha
Employees
2,700
Employees2,700
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
1991
Founded1991
Employees
2,700
Employees2,700

MYGN Key Statistics

Market cap
379.73M
Market cap379.73M
Price-Earnings ratio
-3.32
Price-Earnings ratio-3.32
Dividend yield
—
Dividend yield—
Average volume
1.69M
Average volume1.69M
High today
$4.34
High today$4.34
Low today
$3.97
Low today$3.97
Open price
$4.34
Open price$4.34
Volume
1.40M
Volume1.40M
52 Week high
$8.50
52 Week high$8.50
52 Week low
$2.74
52 Week low$2.74

Stock Snapshot

With a market cap of 379.73M, Myriad Genetics(MYGN) trades at $3.98. The stock has a price-to-earnings ratio of -3.32.

During the trading session on 2026-10-18, Myriad Genetics(MYGN) shares reached a daily high of $4.34 and a low of $3.97. At a current price of $3.98, the stock is +0.3% higher than the low and still -8.3% under the high.

Trading activity shows a volume of 1.4M, compared to an average daily volume of 1.69M.

The stock's 52-week range extends from a low of $2.74 to a high of $8.50.

The stock's 52-week range extends from a low of $2.74 to a high of $8.50.

MYGN News

Simply Wall St 3d
What Myriad Genetics Doubters Saw Before The Drop - Simply Wall Street

...

What Myriad Genetics Doubters Saw Before The Drop - Simply Wall Street
TipRanks 6d
Myriad Genetics price target raised to $4.50 from $4 at TD Cowen

TD Cowen raised the firm’s price target on Myriad Genetics (MYGN) to $4.50 from $4 and keeps a Hold rating on the shares. The firm adjusted targets in the diagn...

Analyst ratings

56%

of 9 ratings
Buy
11.1%
Hold
55.6%
Sell
33.3%

People also own

Based on the portfolios of people who own MYGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.